GRCE: Grace Therapeutics, Inc. Stock

by  •  • Comments Off on GRCE: Grace Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.85
Enterprise Value ($M) 16.79
Book Value ($M) 52.14
Book Value / Share 3.80
Price / Book 0.53
NCAV ($M) 2.85
NCAV / Share 0.21
Price / NCAV 9.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.21

Liquidity (mrq)
Quick Ratio 6.06
Current Ratio 6.06

Balance Sheet (mrq) ($M)
Current Assets 11.94
Assets 61.22
Liabilities 9.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-29 13G/A Hirschman Orin 5.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-19 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2025-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-11-13 10-Q UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 3,293 19,400 16.97
2025-04-16 1,890 8,411 22.47
2025-04-15 1,092 7,941 13.75

(click for more detail)

Similar Companies
GNLX – Genelux Corporation GNPX – Genprex, Inc.
GOVX – GeoVax Labs, Inc. GTBP – GT Biopharma, Inc.
GYRE – Gyre Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io